|
Originally published In Press as doi:10.1074/jbc.C100325200 on June 25, 2001
J. Biol. Chem., Vol. 276, Issue 32, 30183-30187, August 10, 2001
The Human Type 2 Iodothyronine Deiodinase Is a Selenoprotein
Highly Expressed in a Mesothelioma Cell Line*
Cyntia
Curcio,
Munira M. A.
Baqui,
Domenico
Salvatore,
Bertrand H.
Rihn ,
Steve
Mohr ,
John W.
Harney,
P. Reed
Larsen, and
Antonio C.
Bianco§
From the Department of Medicine, Thyroid Division, Brigham
and Women's Hospital and Harvard Medical School, Boston, Massachusetts
02115 and Institut National de Recherche et de Securite,
54501 Vandoeuvre Cedex, France
Types 1 and 3 iodothyronine
deiodinases are known to be selenocysteine-containing enzymes. Although
a putative human type 2 iodothyronine deiodinase (D2) gene
(hDio2) encoding a similar selenoprotein has been
identified, basal D2 activity is not selenium (Se)-dependent nor has D2 been labeled with
75Se. A human mesothelioma cell line (MSTO-211H) has
recently been shown to have ~40-fold higher levels of
hDio2 mRNA than mesothelial cells. Mesothelioma cell
lysates activate thyroxine (T4) to
3,5,3'-triiodothyronine with typical characteristics of D2 such
as low Km (T4), 1.3 nM,
resistance to propylthiouracil, and a short half-life (~30 min). D2
activity is ~30-fold higher in Se-supplemented than in Se-depleted
medium. An antiserum prepared against a peptide deduced from the
Dio2 mRNA sequence precipitates a 75Se
protein of the predicted 31-kDa size from 75Se-labeled
mesothelioma cells. Bromoadenosine 3'5' cyclic monophosphate increases
D2 activity and 75Se-p31 ~2.5-fold whereas substrate
(T4) reduces both D2 activity and 75Se-p31
~2-3-fold. MG132 or lactacystin (10 µM), inhibitors of the proteasome pathway by which D2 is degraded, increase both D2
activity and 75Se-p31 3-4-fold and prevent the loss of D2
activity during cycloheximide or substrate (T4) exposure.
Immunocytochemical studies with affinity-purified anti-hD2 antibody
show a Se-dependent increase in immunofluorescence. Thus,
human D2 is encoded by hDio2 and is a member of the
selenodeiodinase family accounting for its highly catalytic efficiency
in T4 activation.
*
This work was supported by National Institutes of Health
Research Grants DK36256 and DK58538.The costs of publication of this article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
To whom correspondence should be addressed: Brigham and Women's
Hospital, 77 Ave. Louis Pasteur, HIM Bldg. 550, Boston, MA 02115. Tel.:
617-525-5158; Fax: 617-731-4718; E-mail:
abianco@rics.bwh.harvard.edu.
Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
B. Gereben, A. M. Zavacki, S. Ribich, B. W. Kim, S. A. Huang, W. S. Simonides, A. Zeold, and A. C. Bianco
Cellular and Molecular Basis of Deiodinase-Regulated Thyroid Hormone Signaling
Endocr. Rev.,
December 1, 2008;
29(7):
898 - 938.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Piehl, T. Heberer, G. Balizs, T. S. Scanlan, R. Smits, B. Koksch, and J. Kohrle
Thyronamines Are Isozyme-Specific Substrates of Deiodinases
Endocrinology,
June 1, 2008;
149(6):
3037 - 3045.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. D. V. Sagar, B. Gereben, I. Callebaut, J.-P. Mornon, A. Zeold, W. S. da Silva, C. Luongo, M. Dentice, S. M. Tente, B. C. G. Freitas, et al.
Ubiquitination-Induced Conformational Change within the Deiodinase Dimer Is a Switch Regulating Enzyme Activity
Mol. Cell. Biol.,
July 1, 2007;
27(13):
4774 - 4783.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. S. da-Silva, J. W. Harney, B. W. Kim, J. Li, S. D.C. Bianco, A. Crescenzi, M. A. Christoffolete, S. A. Huang, and A. C. Bianco
The Small Polyphenolic Molecule Kaempferol Increases Cellular Energy Expenditure and Thyroid Hormone Activation
Diabetes,
March 1, 2007;
56(3):
767 - 776.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Zeold, M. Doleschall, M. C. Haffner, L. P. Capelo, J. Menyhert, Z. Liposits, W. S. da Silva, A. C. Bianco, I. Kacskovics, C. Fekete, et al.
Characterization of the Nuclear Factor-{kappa}B Responsiveness of the Human dio2 Gene
Endocrinology,
September 1, 2006;
147(9):
4419 - 4429.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. Christoffolete, R. Ribeiro, P. Singru, C. Fekete, W. S. da Silva, D. F. Gordon, S. A. Huang, A. Crescenzi, J. W. Harney, E. C. Ridgway, et al.
Atypical Expression of Type 2 Iodothyronine Deiodinase in Thyrotrophs Explains the Thyroxine-Mediated Pituitary Thyrotropin Feedback Mechanism
Endocrinology,
April 1, 2006;
147(4):
1735 - 1743.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. A. de Jesus, P. R. Hoffmann, T. Michaud, E. P. Forry, A. Small-Howard, R. J. Stillwell, N. Morozova, J. W. Harney, and M. J. Berry
Nuclear Assembly of UGA Decoding Complexes on Selenoprotein mRNAs: a Mechanism for Eluding Nonsense-Mediated Decay?
Mol. Cell. Biol.,
March 1, 2006;
26(5):
1795 - 1805.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Fekete, P. S. Singru, E. Sanchez, S. Sarkar, M. A. Christoffolete, R. S. Riberio, W. M. Rand, C. H. Emerson, A. C. Bianco, and R. M. Lechan
Differential Effects of Central Leptin, Insulin, or Glucose Administration during Fasting on the Hypothalamic-Pituitary-Thyroid Axis and Feeding-Related Neurons in the Arcuate Nucleus
Endocrinology,
January 1, 2006;
147(1):
520 - 529.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Kohrle, F. Jakob, B. Contempre, and J. E. Dumont
Selenium, the Thyroid, and the Endocrine System
Endocr. Rev.,
December 1, 2005;
26(7):
944 - 984.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Morimura, K. Tsunekawa, T. Kasahara, K. Seki, T. Ogiwara, M. Mori, and M. Murakami
Expression of Type 2 Iodothyronine Deiodinase in Human Osteoblast Is Stimulated by Thyrotropin
Endocrinology,
April 1, 2005;
146(4):
2077 - 2084.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. H. A. Gouveia, M. A. Christoffolete, C. R. Zaitune, J. M. Dora, J. W. Harney, A. L. Maia, and A. C. Bianco
Type 2 Iodothyronine Selenodeiodinase Is Expressed throughout the Mouse Skeleton and in the MC3T3-E1 Mouse Osteoblastic Cell Line during Differentiation
Endocrinology,
January 1, 2005;
146(1):
195 - 200.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Fekete, B. Gereben, M. Doleschall, J. W. Harney, J. M. Dora, A. C. Bianco, S. Sarkar, Z. Liposits, W. Rand, C. Emerson, et al.
Lipopolysaccharide Induces Type 2 Iodothyronine Deiodinase in the Mediobasal Hypothalamus: Implications for the Nonthyroidal Illness Syndrome
Endocrinology,
April 1, 2004;
145(4):
1649 - 1655.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. W. Kim, A. M. Zavacki, C. Curcio-Morelli, M. Dentice, J. W. Harney, P. R. Larsen, and A. C. Bianco
Endoplasmic Reticulum-Associated Degradation of the Human Type 2 Iodothyronine Deiodinase (D2) is Mediated via an Association between Mammalian UBC7 and the Carboxyl Region of D2
Mol. Endocrinol.,
December 1, 2003;
17(12):
2603 - 2612.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. P. Peeters, H. van Toor, W. Klootwijk, Y. B. de Rijke, G. G. J. M. Kuiper, A. G. Uitterlinden, and T. J. Visser
Polymorphisms in Thyroid Hormone Pathway Genes Are Associated with Plasma TSH and Iodothyronine Levels in Healthy Subjects
J. Clin. Endocrinol. Metab.,
June 1, 2003;
88(6):
2880 - 2888.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Curcio-Morelli, B. Gereben, A. M. Zavacki, B. W. Kim, S. Huang, J. W. Harney, P. R. Larsen, and A. C. Bianco
In Vivo Dimerization of Types 1, 2, and 3 Iodothyronine Selenodeiodinases
Endocrinology,
March 1, 2003;
144(3):
937 - 946.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Montero-Pedrazuela, J. Bernal, and A. Guadano-Ferraz
Divergent Expression of Type 2 Deiodinase and the Putative Thyroxine-Binding Protein p29, in Rat Brain, Suggests that They Are Functionally Unrelated Proteins
Endocrinology,
March 1, 2003;
144(3):
1045 - 1052.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. W. Kim, G. H. Daniels, B. J. Harrison, A. Price, J. W. Harney, P. R. Larsen, and A. P. Weetman
Overexpression of Type 2 Iodothyronine Deiodinase in Follicular Carcinoma as a Cause of Low Circulating Free Thyroxine Levels
J. Clin. Endocrinol. Metab.,
February 1, 2003;
88(2):
594 - 598.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Fekete, S. Sarkar, W. M. Rand, J. W. Harney, C. H. Emerson, A. C. Bianco, A. Beck-Sickinger, and R. M. Lechan
Neuropeptide Y1 and Y5 Receptors Mediate the Effects of Neuropeptide Y on the Hypothalamic-Pituitary-Thyroid Axis
Endocrinology,
December 1, 2002;
143(12):
4513 - 4519.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Fekete, S. Sarkar, W. M. Rand, J. W. Harney, C. H. Emerson, A. C. Bianco, and R. M. Lechan
Agouti-Related Protein (AGRP) Has a Central Inhibitory Action on the Hypothalamic-Pituitary-Thyroid (HPT) Axis; Comparisons between the Effect of AGRP and Neuropeptide Y on Energy Homeostasis and the HPT Axis
Endocrinology,
October 1, 2002;
143(10):
3846 - 3853.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Botero, B. Gereben, C. Goncalves, L. A. de Jesus, J. W. Harney, and A. C. Bianco
Ubc6p and Ubc7p Are Required for Normal and Substrate-Induced Endoplasmic Reticulum-Associated Degradation of the Human Selenoprotein Type 2 Iodothyronine Monodeiodinase
Mol. Endocrinol.,
September 1, 2002;
16(9):
1999 - 2007.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Mohr, G. D. Leikauf, G. Keith, and B. H. Rihn
Microarrays as Cancer Keys: An Array of Possibilities
J. Clin. Oncol.,
July 15, 2002;
20(14):
3165 - 3175.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Gereben, A. Kollar, J. W. Harney, and P. R. Larsen
The mRNA Structure Has Potent Regulatory Effects on Type 2 Iodothyronine Deiodinase Expression
Mol. Endocrinol.,
July 1, 2002;
16(7):
1667 - 1679.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. G. J. M. Kuiper, W. Klootwijk, and T. J. Visser
Substitution of Cysteine for a Conserved Alanine Residue in the Catalytic Center of Type II Iodothyronine Deiodinase Alters Interaction with Reducing Cofactor
Endocrinology,
April 1, 2002;
143(4):
1190 - 1198.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. C. Bianco, D. Salvatore, B. Gereben, M. J. Berry, and P. R. Larsen
Biochemistry, Cellular and Molecular Biology, and Physiological Roles of the Iodothyronine Selenodeiodinases
Endocr. Rev.,
February 1, 2002;
23(1):
38 - 89.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|